A new drug, camptothecin, has been used to study the The plant alkaloid, camptothecin, has shown antitumor activity against Walker 256 rat carcinosarcoma, murine leukemia L1210, K1964, L5178Y (1-4), and solid tumors (5). Horwitz, Chang, and Grollman (6, 7) reported that camptothecin rapidly inhibited RNA and DNA synthesis in HeLa cells, and that the inhibition of RNA synthesis was readily reversed by removal of the drug from the medium. A closer examination revealed that camptothecin inhibited the labeling of ribosomal RNA; transfer RNA was not affected (7). Other preliminary reports indicate that camptothecin inhibits the incorporation of thymidine and uridine into those nucleic acids of cultured L1210 murine leukemic cells that are made in the nucleus, but not those of the mitochondria (8)*t. It is also inactive against Escherichia coli RNA polymerase (6) (7) (8) . The present study examines the effect of camptothecin on ribosomal RNA synthesis and on ribosomal protein accumulation and utilization in the nucleoli of HeLa cells. Some data concerning the effect of camptothecin on the synthesis of heterogeneously sedimenting nuclear RNA are also presented.
Ribosomnal proteins made in the presence of camptothecin do not accumulate in the nucleolus, and are not subsequently used to form ribosomes if RNA synthesis is allowed to resume.
The plant alkaloid, camptothecin, has shown antitumor activity against Walker 256 rat carcinosarcoma, murine leukemia L1210, K1964, L5178Y (1) (2) (3) (4) , and solid tumors (5) . Horwitz, Chang, and Grollman (6, 7) reported that camptothecin rapidly inhibited RNA and DNA synthesis in HeLa cells, and that the inhibition of RNA synthesis was readily reversed by removal of the drug from the medium. A closer examination revealed that camptothecin inhibited the labeling of ribosomal RNA; transfer RNA was not affected (7) . Other preliminary reports indicate that camptothecin inhibits the incorporation of thymidine and uridine into those nucleic acids of cultured L1210 murine leukemic cells that are made in the nucleus, but not those of the mitochondria (8)*t. It is also inactive against Escherichia coli RNA polymerase (6) (7) (8) . The present study examines the effect of camptothecin on ribosomal RNA synthesis and on ribosomal protein accumulation and utilization in the nucleoli of HeLa cells. Some data concerning the effect of camptothecin on the synthesis of heterogeneously sedimenting nuclear RNA are also presented.
MATERIALS AND METHODS
Cell Culture. HeLa S3 cells were grown in spinner culture at 4-5 X 106/ml in Eagle's minimal essential medium (9) supplemented with 5% fetal-calf serum.
Abbreviations: HnRNA, heterogeneously sedimenting nuclear RNA; SDS, sodium (10) (11) (12) . The nucleoli were prepared by the method of Penman (10, 11) for the isolation of ribosomal precursor RNA, and by the method of Weinberg et al., (12) for the isolation of nucleolar proteins.
The RNA of cytoplasmic extracts was released by 1% sodium dodecyl sulfate (SDS) and analyzed by sucrose-gradient zonal sedimentation (13) . Nucleolar RNA was released for sedimentation analysis by dissolving the nucleolar pellet in 0.5 M urea-0.5% SDS-0.01 M sodium phosphate (pH 7.2). HnRNA (see below) was isolated from the nuclear supernatant fraction with 1% SDS, followed by 2 volumes of cold 95% ethanol. After 18 hr at -20'C, the RNA was collected by centrifugation at 15,000 X g for 10 min. The RNA was then dissolved in 0.01 M Tris-HCl-0.01 M EDTA-0.1 M NaCl-0.2% SDS and analyzed by sucrose-gradient zonal sedimentation. Ribosomes were prepared by Mg++ precipitation and the subunits were isolated by sucrose gradient sedimentation (14, 15) . Preparation and acrylamide gel analysis of proteins from nascent ribonucleoprotein particles and 50S ribosomal subunits have been described (14) .
Drugs. The sodium salt of camptothecin was kindly provided by Dr. H. B. Wood, Jr. of the National Cancer Institute. 4-mg portions were dissolved in 10 ml of water to make 1 mM solutions and kept at -20°C until use.
RESULTS
Effects of Camptothecin on RNA and Protein Synthesis in HeLa Cells. Two major classes of RNA are synthesized in the nucleus, heterogeneously sedimenting nuclear RNA (HnRNA) and ribosomal precursor RNA (precursor rRNA) (16) . They are made in different locations (17) by different enzymes (18) , and can be distinguished by cell fractionation and sucrose gradient analysis (19) . 5 /M camptothecin causes a severe inhibition of HnRNA synthesis (Fig. 1B) . The inhibition is about 35% at 1 gM, 70% at 5 MM, and 80% at 10 MM. The major effect of moderate doses of the drug is to inhibit specifically the synthesis of larger molecules of HnRNA (Fig. 1B) Recovery of RNA Synthesis. Although Horwitz et al. (7) demonstrated a rapid recovery of total RNA synthesis after removal of camptothecin, we wished to measure specifically the rate of recovery of ribosomal precursor RNA. rRNA synthesis returns to the control rate within 5 min of drug removal (Fig. 2C ). More precise determination of the rate of recovery is difficult, since the washing procedure to remove the drug requires 5-10 min. Appearance of 28S and 18S RNAs in the cytoplasm after drug removal. A 600-ml culture (7 X 105 cells/ml) was divided into two equal parts. 5 MIM camptothecin was added to one 300-ml portion, and the cells were incubated for 15 min. The two 300-ml portions were then further divided into three samples. 100 ml (each) of the control and the drug-treated samples were pulsed with A 1000-ml culture (7 X 106 cells/ml) was pulsed for 10 min with 1 mCi of ['Hiuridine. 250 ml was chilled immediately on crushed frozen Earle's medium (A). The remaining 750 ml was made 5 puM in camptothecin. At 15 and 60 min after the drug treatment, 250-ml aliquots were removed and chilled on frozen Earle's medium (B, C, D, E). Also at 60 min after the drug treatment, 250 ml was centrifuged at 800 X g for 2 min and washed with 100 ml of fresh medium to remove the drug. The cells were then incubated for an additional 30 min in 250 ml of fresh medium (F, G). The nucleolar and cytoplasmic RNA were isolated as described in Methods and analyzed on 15-30% SDS-sucrose gradients. ["4C]Uridine-labeled 28S RNA was added to the nucleolar samples as a marker. Nucleolar RNA was centrifuged at 21,000 rpm for 12 hr in a Spinco SW27 rotor at 280C. The cytoplasmic RNA was centrifuged at 21,000 rpm for 20 Some insight into the processing of the 45S and 32S RNA can be gained from examining the absorbance profiles in Fig. 2 . After 15 min in the presence of camptothecin, no 45S RNA remains and the 45/32S ratio is practically zero (Fig.   2B ). Soon after removal of the drug, 45S RNA synthesis resumes, and because 32S RNA already present is converted to 28S RNA (Figs. 2C , 5B, and D), the 45/32S ratio becomes greater than normal. With time, an equilibrium between the synthesis and processing of ribosomal precursor RNA is established and the 45/32S ratio returns' to normal (Fig. 3) .
Not only transcription of the ribosomal precursor RNA, but also its processing and transport from the nucleus to the cytoplasm are completely recovered after camptothecin treatment. This is shown clearly in Fig. 4 , which compares an untreated culture with one from which camptothecin had just been removed. The rate of appearance of mature ribosomal RNA in the cytoplasm is identical for the two cultures.
Effects of Camptothecin on the Processing of Ribosomal Precursor RNA. Actinomycin D causes a slowdown in the processing of 32S to 28S rRNA (20) . Fig. 5 shows that this is also the case with camptothecin. 10 min of labeling before the addition of drug yields almost exclusively 45S RNA (Fig.   5A ). When camptothecin is added, there is no further incorporation of label into 45S RNA, and the 45S RNA already present is converted to 32S RNA, which stays in the nucleolus, while 18S RNA appears in the cytoplasm (Figs. 5B and C). Even after 60 min, there is very little 28S RNA in the cytoplasm (Fig. 5E) . However, the 32S RNA in the nucleolus is slowly converted to 28S RNA. Polyacrylamide gel analysis of the RNA, shown in Fig. 5D , reveals the presence of 28S RNA. This result is similar to that observed with actinomycin D, and implies that some transcriptional event is required at the time of the conversion of nucleolar 32S RNA to cytoplasmic 28S RNA. The data of Fig. 5 also indicate that there is little or no degradation of ribosomal precursor RNA. This result has also been observed in murine leukemic cells.t
Upon the removal of the drug after 60 min (Figs. 5F and G), 45S RNA synthesis resumes in the nucleolus, and 28S RNA makes its appearance in the cytoplasm within 30 min (Fig.  SG) . Since it normally requires 45 min for 28S RNA to appear in the cytoplasm (Fig. 4) , it seems likely that these molecules derive from the 32S RNA formed during the drug treatment. A 400-mi culture (7 X 106 cells/ml) was centrifuged at 800 X g for 2 miil and resuspended in 200 ml of leucine-free medium supplemented with 5% fetalcalf serum. 100 ml of this preparation was pulsed with 100 MACi of [14C]leucine for 20 min. Camptothecin was added to the other 100 ml to a final concentration of 5 AM and, after a 5-min incubation, the cells were pulsed with 100 MACi of [14C]leucine for 20 min. After 20 min, nonradioactive leucine was added, to a final concentration of 80 mM, to both the control and drug-treated samples. 50 ml was then removed from the control and drug-treated samples and chilled on crushed frozen Earle's medium (A and C). The remaining 50 ml of both cultures was centrifuged at 800 X g for 2 min and washed free of drug and 14C. The cultures were then resuspended in 100 ml of fresh medium that contained 40 mM leucine. 2.5 Hr after the removal of the drug, both cultures were chilled on crushed frozen Earle's medium (B and D). The nucleoli were isolated; proteins were prepared from them and mixed with different amounts of proteins from 50S ribosomal subunits that were uniformally labeled with [3H]leucine, and subjected to gel electrophoresis. The gels were run for 24 hr at 70 V. (A) 20-min pulse, control; (B) 2.5 hr chase, control; (C) 20-mi pulse, drug-treated; (D) 2.5-hr chase, drug removed. 3H 0---0; 14C *-@. the synthesis of small RNA continues in the presence of camptothecin, as was reported by Horwitz et al. (7) (Fig.  5E) . There also appears to be an accumulation of radioactivity throughout the cytoplasmic gradient that is probably mRNA.
Effect of Camptothecin on Ribosomal Protein Utilization. Noncoordinate synthesis of ribosomal RNA and ribosomal proteins has been demonstrated in L cells by Craig and Perry, who found that ribosomal protein synthesis continues in the presence of low doses of actinomycin D, and that this protein is not used in ribosome formation if ribosomal RNA synthesis resumes several hours later (21, 22) . We explored whether such protein can be found in the nucleolus after its synthesis, and whether it can be used to form ribosomes when ribosomal RNA synthesis resumes. A culture was treated with 5 MM camptothecin. After 5 min, ['4C ]leucine was added. 20 min later, an excess of unlabeled leucine was added and the culture divided into two aliquots, one of which was chilled while the other was washed free of camptothecin, resuspended in fresh medium, and harvested after 150 min of further growth. A control culture was treated in the same way, except that no drug was present. The total incorporation of ["4CIleucine was the same for both cultures. The nucleoli and the 50S ribosomal subunits were purified, and their proteins were analyzed by gel electrophoresis. The results are shown in Figs. 6 and 7.
Two classes of proteins are found in the nucleolus of the HeLa cell (23) . The bulk of the nucleolar proteins are ribosomal structural proteins. These combine with ribosomal precursor RNA to form nascent ribosomes (24) , and are eventually exported to the cytoplasm. This export can be seen by comparison of Fig. 6A and B, which illustrate the loss of ribosomal proteins from the nucleolus, and Fig. 7B , which indicates the appearance of these proteins in cytoplasmic ribosomes. The other class of labeled nucleolar proteins, most of which are larger than the ribosomal proteins and are found in fractions [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] , are true nucleolar proteins that remain in the nucleolus after a chase (Fig. 6B) (23) . There are also two classes of ribosomal proteins in the cytoplasmic 50S subunits. In addition to ribosomal structural proteins, there is another class that does not participate in new ribosome synthesis but is reversibly associated with old ribosomes (14) . The peak in fractions 28-30 of Fig. 7A and C demonstrates this point very clearly. Consistent with the lack of ribosomal structural proteins in the nucleolus after treatment with camptothecin ( Fig. 6C) , no ribosomal proteins appear associated with cytoplasmic subunits after normal RNA synthesis is measured (Fig. 7D) . Examination of Fig. 6C and D reveals that the amount of radioactive proteins that can be found in the nucleolus after pulse labeling with ['4C]leucine in the presence of camptothecin is greatly reduced, even though total protein synthesis is unaffected. The true nucleolar proteins (fractions 1-16), however, are not altered. By estimation of the contribution of true nucleolar proteins (from Fig. 6B and D) , it may be calculated that the inhibition of appearance of ribosomal proteins in the nucleolus is 80%. When the prior incubation in the presence of the drug was increased from 5 to 100 min, no further inhibition of accumulation of ribosomal proteins occurred. DISCUSSION 
Effects of camptothecin on RNA synthesis
Our results confirm that camptothecin is a potent inhibitor of RNA synthesis in HeLa cells (7) . This drug exhibits a differential effect on the synthesis of the various classes of nuclear RNA. The synthesis of ribosomal precursor RNA is more sensitive, being 95% inhibited at 5 ,M. Furthermore, camptothecin affects a specific step in the maturation of ribosomal precursor RNA. While 45S RNA is converted to 32S RNA normally in the nucleolus, the appearance of 28S RNA in the cytoplasm is inhibited. The most notable feature about camptothecin is its rapid reversibility. Within minutes after the removal of camptothecin, the synthesis of 45S RNA and its maturation to functional ribosomes is completely normal (Figs. 2 and 4) .
Effects of camptothecin on ribosomal protein
The rapidity and efficiency of recovery allows us to use camptothecin as a tool to study the interrelationship of rRNA synthesis and ribosomal protein accumulation within the nucleolus. Craig and-Perry (21) have shown that the inhibition of RNA synthesis for a brief time does not affect the rate of ribosomal protein synthesis.
We find that when RNA synthesis is interrupted by camptothecin, very little of the ribosomal structural proteins is found in the nucleolus, while the true nucleolar proteins appear in amounts close to normal. Furthermore, on removal of the drug, only those ribosomal structural proteins already in the nucleolus become associated with cytoplasmic ribosomes. The synthesis and assembly of a class of proteins that is reversibly associated with cytoplasmic ribosomes (Figs. 7A and C, fractions 29-30) is unaffected by the interruption in precursor rRNA synthesis due to camptothecin treatment. These results suggest that precursor rRNA plays an important role in stabilizing newly formed ribosomal proteins in the nucleolus. Furthermore, those ribosomal proteins that are not within the nucleolus must be degraded, since they never become evident, even after the drug has been removed.
